Meeting with the European Commission on Artificial Intelligence

On 6 July, PGEU met with European Commission (EC) DG CNECT official in order to discuss the content of the EC Proposal for a Regulation on Artificial Intelligence (AI). The key points discussed were the conformity assessment procedures for medical devices which have a high-risk AI system component and the interaction of the AI Regulation with the relevant sectorial Regulations 745/2017 and 746/2017 listed in the Annex II of the AI Regulation.

On 20 July, PGEU submitted its feedback on the European Commission Proposal for an EU Regulation on Artificial Intelligence, expressing support the European Commission’s general objective to ensure that the development and uptake of AI across the Single Market is conducted in a trustworthy way. While we see great value in using AI in healthcare for enabling meaningful innovation, supporting health professionals and enhancing patient care, we are aware that it may also entail significant risks, for example in relation to the use of health and patient data. Therefore we support the Proposal put forward by the European Commission as it provides a good basis to address use of AI systems which may affect health and safety of users and consumers as well as their fundamental rights.

January

April

February

March

June

September

July

August

October

November

December

2021 at a glance

May

PGEU Annual Report 2021

Community pharmacists exemplar role as primary care providers in the COVID-19 pandemic

11